Simon Jones and Gordan Alexander, both of Prisym ID, explore the added complexity to the labeling of trial supplies that new regulations to EU 536/2014 will bring, specifically Annex VI.
Gordan Alexander
Advertisement
Articles by Gordan Alexander
Advertisement
Latest Updated Articles
- Labeling Challenges from EU Annex VI
Published: September 6th 2019 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Bringing Clinical Trials Into the Digital Era with eConsent
2
Global Breast Cancer Trials Show Progress in Diversity, But Gaps Remain
3
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
4
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
